TRxADE HEALTH Files 8-K for Financials

Ticker: SCNX · Form: 8-K · Filed: May 23, 2024 · CIK: 1382574

Trxade Health, Inc 8-K Filing Summary
FieldDetail
CompanyTrxade Health, Inc (SCNX)
Form Type8-K
Filed DateMay 23, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.00001, $2,500,000
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financial-statements, exhibits

TL;DR

TRxADE HEALTH filed an 8-K for routine financial updates.

AI Summary

On May 23, 2024, TRxADE HEALTH, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rather than a significant event. The company, incorporated in Delaware, operates in the wholesale drug and sundries sector.

Why It Matters

This 8-K filing serves as a standard disclosure for TRxADE HEALTH, INC., providing updates on financial statements and exhibits to the SEC.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate operational or financial distress.

Key Players & Entities

  • TRxADE HEALTH, INC. (company) — Registrant
  • May 23, 2024 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • 5122 (sic_code) — Standard Industrial Classification for Wholesale-Drugs Proprietaries & Druggists' Sundries
  • 2420 Brunello Trace Lutz, Florida 33558 (address) — Principal Executive Offices

FAQ

What is the primary purpose of this 8-K filing for TRxADE HEALTH, INC.?

The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on May 23, 2024.

In which state is TRxADE HEALTH, INC. incorporated?

TRxADE HEALTH, INC. is incorporated in Delaware.

What is the Standard Industrial Classification (SIC) code listed for TRxADE HEALTH, INC.?

The SIC code listed is 5122, which corresponds to Wholesale-Drugs Proprietaries & Druggists' Sundries.

What is the principal executive office address for TRxADE HEALTH, INC.?

The principal executive office address is 2420 Brunello Trace Lutz, Florida 33558.

Filing Stats: 681 words · 3 min read · ~2 pages · Grade level 11.2 · Accepted 2024-05-23 17:00:16

Key Financial Figures

  • $0.00001 — ch registered Common stock, par value $0.00001 per share MEDS The Nasdaq Stock Mar
  • $2,500,000 — was not in compliance with the minimum $2,500,000 stockholders' equity requirement for co

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRxADE HEALTH, INC. By: /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer Date: May 23, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.